» Articles » PMID: 27830012

Human Mesenchymal Stromal Cell-derived Extracellular Vesicles Alleviate Renal Ischemic Reperfusion Injury and Enhance Angiogenesis in Rats

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2016 Nov 11
PMID 27830012
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mesenchymal stromal cells (MSCs) derived extracellular vesicles (EVs) were regarded as a potent medium for kidney injury repair and angiogenesis were regarded as an important step in tissue regeneration. However, the pro-angiogenesis effect of MSC-EVs in ischemia-reperfusion induced kidney injury and its potential mechanisms have yet to be determined.

Methods: EVs were isolated from the medium of human umbilical cord-derived MSCs (huMSCs) were injected in rats intravenously after unilateral kidney ischemia. Animals were sacrificed at 24 h and 2 weeks after injury. The renal functions and histology staining were examined to assess the therapeutic effect of the EVs. Moreover, we investigated the pro-angiogenesis effects of EVs in injured kidneys and tested the angiogenesis-related factors to further illuminate the probable mechanisms.

Results: It was observed that EVs could reduce cell apoptosis and enhances proliferation 24 h after kidney injury, meanwhile renal function was improved and the histological lesion was mitigated. Moreover, renal VEGF was up-regulated by EVs and HIF-1α was down-regulated. Further, the increase of capillary vessel density and reduce of renal fibrosis was observed after 2 weeks. In , EVs could deliver human VEGF directly to renal tubular epithelial cells (TECs) and increase VEGF levels. Most important, all the beneficial effects of EVs were abrogated by RNase treated except for the delivery of human VEGF.

Conclusions: Human MSC-EVs could protect against ischemic/reperfusion injury induced kidney injury through pro-angiogenesis effects in HIF-1α independent manner, and both the delivery of pro-angiogenesis related VEGF and RNAs were involved in this process.

Citing Articles

Osteoporosis under psychological stress: mechanisms and therapeutics.

Xu H, Liu J, Zhou Z, Zheng C, Sui B, Yuan Y Life Med. 2025; 3(1):lnae009.

PMID: 39872391 PMC: 11749647. DOI: 10.1093/lifemedi/lnae009.


Targeting cellular senescence in kidney diseases and aging: A focus on mesenchymal stem cells and their paracrine factors.

Hejazian S, Hejazian S, Mostafavi S, Hosseiniyan S, Montazersaheb S, Ardalan M Cell Commun Signal. 2024; 22(1):609.

PMID: 39696575 PMC: 11657437. DOI: 10.1186/s12964-024-01968-1.


Human umbilical cord mesenchymal stem cells-derived extracellular vesicles ameliorate kidney ischemia-reperfusion injury by suppression of senescent tubular epithelial cells: experimental study.

Ma M, Zeng J, Zhu M, Li H, Lin T, Yang H Int J Surg. 2024; 111(1):394-410.

PMID: 39236098 PMC: 11745712. DOI: 10.1097/JS9.0000000000002074.


Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.

Taherian M, Bayati P, Mojtabavi N Stem Cell Res Ther. 2024; 15(1):170.

PMID: 38886859 PMC: 11184790. DOI: 10.1186/s13287-024-03782-5.


Mechanism of Post-stroke Axonal Outgrowth and Functional Recovery.

Ueno Y Juntendo Iji Zasshi. 2024; 69(5):364-369.

PMID: 38845728 PMC: 10984353. DOI: 10.14789/jmj.JMJ23-0025-R.


References
1.
Wu S, Ju G, Du T, Zhu Y, Liu G . Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS One. 2013; 8(4):e61366. PMC: 3625149. DOI: 10.1371/journal.pone.0061366. View

2.
Gatti S, Bruno S, Deregibus M, Sordi A, Cantaluppi V, Tetta C . Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011; 26(5):1474-83. DOI: 10.1093/ndt/gfr015. View

3.
Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C . Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007; 292(5):F1626-35. DOI: 10.1152/ajprenal.00339.2006. View

4.
Rani S, Ryan A, Griffin M, Ritter T . Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol Ther. 2015; 23(5):812-823. PMC: 4427881. DOI: 10.1038/mt.2015.44. View

5.
Schrier R, Wang W, Poole B, Mitra A . Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004; 114(1):5-14. PMC: 437979. DOI: 10.1172/JCI22353. View